Goodwill and Other Intangible Assets (Tables)

9 Months Ended

Mar. 30, 2013

Goodwill and Intangible Assets Disclosure [Abstract]

Schedule of Goodwill [Table Text Block]

Changes in the carrying amount of goodwill, by reportable segment, were as follows:

	Consumer Healthcare			Nutritionals		Rx Pharmaceuticals		API		Total
Balance as of June 30, 2012	$	138,910		$	331,744	$	220,769	$	86,334	$	777,757
Business acquisitions	80,229			—		160,959		—		241,188
Currency translation adjustment	(960		)	—		622		6,033		5,695
Balance as of March 30, 2013	$	218,179		$	331,744	$	382,350	$	92,367	$	1,024,640

Schedule of Finite and Indefinite-Lived Intangible Assets [Table Text Block]

Other intangible assets and related accumulated amortization consisted of the following:

	March 30, 2013				June 30, 2012				March 31, 2012
	Gross		Accumulated Amortization		Gross		Accumulated Amortization		Gross		Accumulated Amortization
Amortizable intangibles:
Developed product technology/formulation and product rights	$	779,570	$	187,377	$	542,094	$	140,489	$	549,356	$	131,815
Customer relationships	351,236		67,086		341,363		50,757		342,405		46,259
Distribution, license and supply agreements	81,566		28,991		52,609		23,686		53,004		22,838
Non-compete agreements	10,708		5,470		7,804		3,778		7,853		3,419
Trademarks	5,110		722		4,797		704		5,026		713
Total	1,228,190		289,646		948,667		219,414		957,644		205,044
Non-amortizable intangibles:
In-process research and development	46,255		—		35,000		—		35,000		—
Trade names and trademarks	57,059		—		7,365		—		7,481		—
Total other intangible assets	$	1,331,504	$	289,646	$	991,032	$	219,414	$	1,000,125	$	205,044

Schedule of Intangible Assets, Future Amortization Expense [Table Text Block]

The estimated amortization expense for each of the following five years is as follows:

Fiscal Year	Amount
2013(1)	$	27,300
2014	108,700
2015	107,500
2016	104,900
2017	102,300

⁽¹⁾Reflects remaining three months of fiscal 2013.